A pilot clinical trial to determine the potentials of a 3-day, 200 mg 6 hourly course of Rifaximin by comparing its efficacy with that of a 3-day, 500 mg 12 hourly dose of ciprofloxacin in the treatment of adults with clinically severe cholera due to V. cholerae O1 or O139
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Salam, M.A. | - |
| dc.date.accessioned | 2012-11-15T05:29:28Z | - |
| dc.date.available | 2012-11-15T05:29:28Z | - |
| dc.date.issued | 2005 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/4123 | - |
| dc.format.extent | 397824 bytes | - |
| dc.format.mimetype | application/msword | - |
| dc.language.iso | en | en |
| dc.relation.ispartofseries | ICDDRB research protocol no. 2005-009 | en |
| dc.subject | Vibrio cholerae | en |
| dc.subject | Ciprofloxacin | en |
| dc.subject | Bangladesh | en |
| dc.title | A pilot clinical trial to determine the potentials of a 3-day, 200 mg 6 hourly course of Rifaximin by comparing its efficacy with that of a 3-day, 500 mg 12 hourly dose of ciprofloxacin in the treatment of adults with clinically severe cholera due to V. cholerae O1 or O139 | en |
| dc.type | Other | en |
| Appears in Collections: | Clinical sciences research protocols | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ICDDRBProtocol-2005-009.doc | 388.5 kB | Microsoft Word | View/Open |
This item is protected by original copyright |